ERA PerMed Newsletter published

14 January 2022 – In their just published 7th Newsletter, ERA PerMed presents the projects funded under Joint Transnational Call 2021 “development of clinical support tools for personalised medicine implementation”.

22 successful consortia are funded under the 2021 ERA PerMed call, with a total investment of approximately 27 million Euros for three years. The topics of the excellent projects that were selected for funding include a broad range of different diseases, such as cancer, renal diseases, cardiovascular diseases, chronic obstructive pulmonary diseases, neurological diseases, rheumatoid arthritis and systemic auto-inflammatory diseases. 

The newsletter presents the topics, objectives and researchers involved in the successful consortia and is available here

ERA PerMed is an ERA-Net Cofund, supported by 32 partners of 23 countries and co-funded by the European Commission. 

Please note: The current ERA PerMed Joint Transnational Call “Prevention in Personalised Medicine” is still open for applications until February 17, 2022. More information is available here.